Treating Asthma: A Pharmacological Approach

Treating Asthma: A Pharmacological Approach
A desktop/laptop computer is required to access this course
2 CE Credit Hours
$9.95

This course introduces participants to the symptoms and etiology of asthma and the underlying pathophysiology of the disease and covered important points about the evaluation of the patient with asthma and important teaching points in patient education. Pharmacologic therapies discussed include: Anti-inflammatory agents (corticosteroids and cromolyn), bronchodilators (short and long-acting beta2-adrenergic agonists), leukotriene modifiers, IgE antagonists (omalizumab), anticholinergic drugs and methylxanthines.

Description

Details

Completion Requirements

In order to receive full contact-hour credit for this CE activity, participants must:

  1. Be registered for this activity,
  2. Review the course material,
  3. Complete the course post-test and obtain a grade of 70% or higher,
  4. Complete and submit the course evaluation survey.
  5. Other requirements for some of the courses may also include participation discussion boards, practice exercises, practice questions, etc.

Conflict of Interest (or lack thereof) for Planners, Authors and Presenters.

A conflict of interest exists if any individual/entity that is in a position to influence the content, design, or implementation of the CNE activity is ALSO in a position to benefit financially from the success of a CE activity.

The planners, authors and presenters of this CNE activity have disclosed no conflict of interest including no relevant financial relationships with any commercial companies pertaining to this CNE activity.

Commercial/Sponsor Support.

There is no commercial company or sponsor support for this CE activity.

Non-Endorsement of Products.

The CE provider approval status refers only to continuing nursing education activities and does not imply that there is a real or implied endorsement of any product, service, or company referred to in this activity nor of any company subsidizing costs related to the activity.

Off-Label Product Use.

This CE activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).

Course Aprrovals

Nursing Board Approvals National Healthcare Institute (NHI) is an approved provider of continuing nursing education by the Florida and District of Columbia Board of Nursing. All CE courses offer by National Healthcare Institute follow the standards recommended by the American Nurses Credentialing Center’s Commission on Accreditation for this type of educational activities.

Florida Board of Nursing

Registered Nurse

Clinical Nurse Specialist

Advanced Registered Nurse Practitioner

District of Columbia Board of Nursing

Registered Nurse

Registered Nurse Anesthetist

Clinical Nurse Specialist

Clinical Nurse Midwife

Advanced Registered Nurse Practitioner

Georgia Board of Nursing

Registered Nurse

You may also be interested in the following course(s)